References
- Been, M. and Cech, T. (1986) One binding site determinessequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity. Cell 47, 207-216. https://doi.org/10.1016/0092-8674(86)90443-5
- Bukh, J., Purcell, R. H. and Miller, R. H. (1992) Sequenceanalysis of 5’ noncoding region of hepatitis C virus. Proc.Natl. Acad. Sci. USA 89, 4942-4946. https://doi.org/10.1073/pnas.89.11.4942
- Choo, Q. -L. Richman, K. H., Han, J. H., Berger, K., Lee, C.,Dong, C., Gallegos, C., Coit, D., Medina-Selby, A., Barr, P. J.,Weiner, A. J., Bradley, D. W., Kuo, G. and Houghton, M.(1991) Genetic organization and diversity of the hepatitis Cvirus. Proc. Natl. Acad. Sci. USA 88, 2451-2455. https://doi.org/10.1073/pnas.88.6.2451
- Chung, J. H., Park, H. -Y., Lee, J. H. and Jang, Y. (2002)Identification of the dITP- and XTP-hydrolyzing protein fromEscherichia coli. J. Biochem. Mol. Biol. 35, 403-408. https://doi.org/10.5483/BMBRep.2002.35.4.403
- Di Bisceglie, A. M., McHutchison, J. F. and Rice, C. M. (2002)New therapeutic strategies for hepatitis C. Hepatology 35, 224-231. https://doi.org/10.1053/jhep.2002.30531
- Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos,G., Goncales, F. L. Jr., Haussinger, D., Diago, M., Carosi, G.,Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J. and Yu, J.(2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitisC virus infection. N. Engl. J. Med. 347, 975-982. https://doi.org/10.1056/NEJMoa020047
- Hahm, B., Kim, Y. K., Kim, J. H., Kim, T. Y. and Jang, S. K.(1998) Heterogeneous nuclear ribonucleoprotein L interactswith the 3’ border of the internal ribosomal entry site ofhepatitis C virus. J. Virol. 72, 8782-8788.
- Hanecak, R., Browndriver, V., Fox, M. C., Azad, R. F., Furusako,S., Nozaki, C., Ford, C., Sasmor, H. and Anderson, K. P.(1996) Antisense oligonucleotide inhibition of hepatitis C virusgene expression in transformed hepatocytes. J. Virol. 70, 5203-5212.
- Honda, M., Beard, M. R., Ping, L. H. and Lemon, S. M. (1999)A phylogenetically conserved stem-loop structure at the 5'border of the internal ribosome entry site of hepatitis C virus isrequired for cap-independent viral translation. J. Virol. 73,1165-1174.
- Jones, J. T., Lee, S. -W. and Sullenger, B. A. (1996) Taggingribozyme reaction sites to follow trans-splicing in mammaliancells. Nat. Med. 2, 643-648. https://doi.org/10.1038/nm0696-643
- Jones, J. T. and Sullenger, B. A. (1997) Evaluating and enhancingribozyme reaction efficiency in mammalian cells. Nat.Biotechnol. 15, 902-905. https://doi.org/10.1038/nbt0997-902
- Kapadia, S. B., Brideau-Anderson, A. and Chisari, F. V. (2003)Interference of hepatitis C virus RNA replication by shortinterfering RNAs. Proc. Natl. Acad. Sci. USA 100, 2014-2018. https://doi.org/10.1073/pnas.252783999
- Kim, H. S. and Park, Y. S. (2002) Effect of lipid compositions ongene transfer into 293 cells using sendai F/HN-virosomes. J.Biochem. Mol. Biol. 35, 459-464. https://doi.org/10.5483/BMBRep.2002.35.5.459
-
Lan, N., Howrey, R. P., Lee, S. -W., Smith, C. A. and Sullenger,B. A. (1998) Ribozyme-mediated repair of sickle
${\beta}β-globin$ mRNAs in erythrocyte precursors. Science 280, 1593-1596. https://doi.org/10.1126/science.280.5369.1593 - Lan, N., Rooney, B. L., Lee, S. -W., Howrey, R. P., Smith, C. A.and Sullenger, B. A. (2000) Enhancing RNA repair efficiencyby combining trans-splicing ribozymes that recognize differentaccessible sites on a target RNA. Mol. Ther. 2, 245-255. https://doi.org/10.1006/mthe.2000.0125
- Lauer, G. M. and Waker, B. D. (2001) Hepatitis C virus infection.N. Engl. J. Med. 345, 41-52. https://doi.org/10.1056/NEJM200107053450107
- Lieber, A., He, C. Y., Polyak, S. J., Gretch, D. R., Barr, D. andKay, M. A. (1996) Elimination of hepatitis C virus RNA ininfected human hepatocytes by adenovirus-mediated expressionof ribozymes. J. Virol. 70, 8782-8791.
- Macejak, D. G., Jensen, K. L., Jamison, S. F., Domenico, K., Roberts, E. C., Chaudhary, N., von Carlowitz, I., Bellon, L.,Tong, M. J., Conrad, A., Pavco, P. A. and Blatt, L. M. (2000)Inhibition of hepatitis C virus (HCV)-RNA-dependenttranslation and replication of a chimeric HCV poliovirus usingsynthetic stabilized ribozymes. Hepatology 31, 769-776. https://doi.org/10.1002/hep.510310331
- Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K.,Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K.,Ling, M. and Albrecht, J. K. (2001) Peginterferon alfa-2b plusribavirin compared with interferon alfa-2b plus ribavirin forinitial treatment of chronic hepatitis C: a randomised trial.Lancet 358, 958-965. https://doi.org/10.1016/S0140-6736(01)06102-5
- Miller, R. H. and Purcell, R. H. (1990) Hepatitis C virus sharesamino acid sequence similarity with pestiviruses andflaviviruses as well as members of two plant virus supergroups.Proc. Natl. Acad. Sci. USA 87, 2057-2061. https://doi.org/10.1073/pnas.87.6.2057
- Phylactou, L. A., Darrah, C. and Wood, M. J. (1998) Ribozyme-mediatedtrans-splicing of a trinucleotide repeat. Nat. Genet.18, 378-381. https://doi.org/10.1038/ng0498-378
- Randall, G., Grakoul, A, and Rice, C. M. (2003) Clearance ofreplicating hepatitis C virus replicon RNAs in cell culture bysmall interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 235-240. https://doi.org/10.1073/pnas.0235524100
- Rogers, C. S., Vanoye, C. G., Sullenger, B. A. and George, Jr., A.L. (2002) Functional repair of a mutant chloride channel usinga trans-splicing ribozyme. J. Clin. Invest. 110, 1783-1798. https://doi.org/10.1172/JCI200216481
- Rosenberg, S. (2001) Recent advances in the molecular biology ofhepatitis C virus. J. Mol. Biol. 313, 451-464. https://doi.org/10.1006/jmbi.2001.5055
- Ryu, K. -J., Kim, J. -H. and Lee, S. -W. (2003) Ribozyme-mediatedselective induction of new gene activity in hepatitis Cvirus internal ribosome entry site-expressing cells by targetedtrans-splicing. Mol. Ther. 7, 386-395. https://doi.org/10.1016/S1525-0016(02)00063-1
- Sakamoto, N., Wu, C. H. and Wu, G. Y. (1996) Intracellularcleavage of hepatitis C virus RNA and inhibition of viralprotein translation by hammerhead ribozymes. J. Clin. Invest.98, 2720-2728. https://doi.org/10.1172/JCI119097
- Shin, K. -S., Bae, S. -J., Hwang, E. -S., Jeong, S. and Lee, S. -W.(2002) Ribozyme-mediated replacement of p53 RNA bytargeted trans-splicing. J. Microbiol. Biotechnol. 12, 844-848.
- Sullenger, B. A. (1996) Ribozyme-mediated repair of RNAsencoding mutant tumor suppressors. Cytokines Mol. Ther. 2,201-206.
- Sullenger, B. A. and Cech, T. R. (1994) Ribozyme-mediated repairof defective mRNA by targeted trans-splicing. Nature 317,619-622.
- Sullenger, B. A. and Gilboa, E. (2002). Emerging clinicalapplications of RNA. Nature 418, 252-258. https://doi.org/10.1038/418252a
- Wang, T. H., Rijnbrand, R. C. and Lemon, S. M. (2000) Coreprotein-coding sequence, but not core protein, modulates theefficiency of cap-independent translation directed by theinternal ribosome entry site of hepatitis C virus. J. Virol. 74,11347-11358. https://doi.org/10.1128/JVI.74.23.11347-11358.2000
- Watanabe, T. and Sullenger, B. A. (2000) Induction of wild-typep53 activity in human cancer cells by ribozymes that repairmutant p53 transcripts. Proc. Natl. Acad. Sci. USA 97, 8490-8494. https://doi.org/10.1073/pnas.150104097
- Welch, P. J., Tritz, R., Yei, S., Leavitt, M., Yu, M. and Barber, J.(1996) A potential therapeutic application of hairpin ribozymes:in vitro and in vivo studies of gene therapy for hepatitis Cvirus infection. Gene Ther. 3, 994-1001.
- Wilson, J. A., Jayasena, S., Khvorova, A., Sabatinos, S., Rodrigue-Gervais, I. G., Arya, S., Sarangi, F., Harris-Brandts, M.,Beaulieu, S. and Richardson, C. D. (2003) RNA interferenceblocks gene expression and RNA synthesis from hepatitis Creplicons propagated in human liver cells. Proc. Natl. Acad.Sci. USA 100, 2783-2788. https://doi.org/10.1073/pnas.252758799
- Witherell, G. W. (2001) ISIS-14803 (ISIS Pharmaceuticals). Curr.Opin. Investig. Drugs. 2, 1523-1529.
- World Health Organization. (1999) Global surveillance and controlof hepatitis C. J Viral Hepat. 6, 35-47. https://doi.org/10.1046/j.1365-2893.1999.6120139.x
Cited by
- Hepatitis C Virus Translation Inhibitors Targeting the Internal Ribosomal Entry Site vol.57, pp.5, 2014, https://doi.org/10.1021/jm401312n
- Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing vol.327, pp.8, 2004, https://doi.org/10.1016/j.crvi.2004.05.008
- Old and emerging therapies in chronic hepatitis C: an update vol.0, pp.0, 2007, https://doi.org/10.1111/j.1365-2893.2007.00887.x
- RNA reprogramming and repair based on trans-splicing group I ribozymes vol.27, pp.3, 2010, https://doi.org/10.1016/j.nbt.2010.02.013
- Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme vol.192, 2014, https://doi.org/10.1016/j.jbiotec.2014.10.001
- Gene Therapy Progress and Prospects: Reprograming gene expression by trans-splicing vol.12, pp.20, 2005, https://doi.org/10.1038/sj.gt.3302596
- Biaryl guanidine inhibitors of in vitro HCV-IRES activity vol.14, pp.20, 2004, https://doi.org/10.1016/j.bmcl.2004.07.066
- Oligomeric Nucleic Acids as Antivirals vol.16, pp.2, 2011, https://doi.org/10.3390/molecules16021271